Ledger.Open graph →
SEC Form D · filed July 10, 2025

NLS Pharmaceutics Ltd

Offering
$1.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
ZURICH, V8
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Alexander Zwyer · Zurich, V8Exec · DirectorGian-Marco L. Rinaldi De La Cruz · Zurich, V8DirectorFlorence Allouche Aknin · Zurich, V8DirectorNicole Fernandez-Mcgovern · Zurich, V8ExecOlivier L. Samuel · Zurich, V8DirectorRonald Hafner · Zurich, V8DirectorNicole Fernandez-Mcgovern · Zurich, V8ExecOlivier L. Samuel · Zurich, V8DirectorFlorence Allouche Aknin · Zurich, V8DirectorGian-Marco L. Rinaldi De La Cruz · Zurich, V8DirectorAlexander Zwyer · Zurich, V8Exec · DirectorRonald Hafner · Zurich, V8DirectorStephen R. Towe · West Sussex, United KingdomDirectorLaray Stover · Grandview, TXExecSteve Leid · Grandview, TXExec · DirectorSeth L. Pearlstein · New York, NYDirectorBrooks C. Deibele · Waukee, IADirectorRichard Greer · Needham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗